Results

Total Results: 10 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

  1. srdrplus.ahrq.gov/published_projects?page=54
    March 03, 2021 - READ MORE Published on March 03, 2021 Decision Aids for Cancer Screening and Treatment 74 Citations … 2021 Last updated on March 03, 2021 Objectives: Background: Many health decisions about screening and treatment … READ MORE Published on March 03, 2021 Therapeutic Management, Delivery, and Postpartum Risk Assessment … diabetes? … of gestational diabetes with an oral diabetes agent or insulin.
  2. srdrplus.ahrq.gov/published_projects?page=49
    June 23, 2021 - and glucagon-like peptide-1 [GLP-1] receptor agonists), as monotherapy and in combination, for the treatment … outcomes (e.g., mortality), and harms (e.g., hypoglycemia) in head-to-head monotherapy or combination therapy … medications can facilitate personalized treatment choices for patients. … READ MORE Published on June 23, 2021 Treatments for Ankyloglossia and Ankyloglossia with Concomitant … We systematically the reviewed the literature on surgical and nonsurgical treatments for infants and
  3. srdrplus.ahrq.gov/published_projects?page=9
    January 17, 2023 - , 3) What are the adverse effects of COPD treatments in this population? … patients and an association of ICS use with the risk of developing diabetes. … observational trials should be interpreted in context of the larger body of literature on harms of inhaled therapies … women over 5.0 to 5.6 years) for colorectal cancer (34 fewer cases), diabetes (78 fewer cases), and … for estrogen plus progestin therapy).
  4. srdrplus.ahrq.gov/published_projects?page=52
    March 07, 2023 - (comparative) benefits and harms of timing of IBR and AR in relation to chemotherapy and radiation therapy … READ MORE Published on March 03, 2021 Catheter Ablation for Treatment of Atrial Fibrillation [Prospectively … READ MORE Published on March 03, 2021 Behavioral programs for diabetes mellitus 166 Citations • 6 Key … 2021 Objectives: A systematic review focusing on the effectiveness of behavioral programs for type 1 diabetes … (T1DM), and identifying factors contributing to program effectiveness for type 2 diabetes (T2DM).
  5. srdrplus.ahrq.gov/published_projects?page=5
    October 12, 2023 - The long-term potential benefits of lipid screening and subsequent treatment are uncertain. … of various lipid-lowering treatments for FH including pharmacotherapy, behavioral counseling, and dietary … One fair-quality observational study evaluated the association of statins and new onset diabetes (n=9,393 … ), showing no difference in new diabetes diagnoses over 9 years followup in those taking statins compared … of various lipid lowering treatments for multifactorial dyslipidemia.
  6. srdrplus.ahrq.gov/published_projects?page=13
    September 14, 2022 - transition clinics may not improve hemoglobin A1C levels either at 12 or 24 months in youth with type 1 diabetes … To identify new evidence published after the 2020 AHRQ review, Opioid Treatments for Chronic Pain (available … READ MORE Published on August 22, 2022 Systematic Review on Nonopioid Pharmacologic Treatments for Chronic … duration (3 to <6 months), intermediate-term treatment duration (6 to <12 months), and long-term treatment … duration (3 to <6 months), intermediate-term treatment duration (6 to <12 months), and long-term treatment
  7. srdrplus.ahrq.gov/published_projects?page=20
    June 27, 2021 - Controlled studies of CLPC (T1-T3a) treatments with duration ≥5 years for mortality and metastases and … We evaluated how patient and tumor characteristics modify treatment outcomes and how provider/hospital … Limited evidence suggested that AS results in fewer harms than photodynamic therapy and laparoscopic … There was little to no information on long-term comparative effectiveness of other treatments. … Little information exists on other treatments or the effects of patient, tumor and provider factors.
  8. srdrplus.ahrq.gov/published_projects?page=43
    June 27, 2021 - of higher adverse effects with combination therapy. … with the newly used drugs or combination therapies. … of chronic physical or mental health conditions (e.g., diabetes, depression, substance abuse). … To assess the efficacy, comparative effectiveness, and harms of treatments for insomnia disorder in the … Pooled estimates were analyzed to assess the efficacy and comparative effectiveness of treatments.
  9. srdrplus.ahrq.gov/published_projects?page=24
    October 31, 2022 - 27, 2021 Three types of hypoglycemic agents (DPP- 4Is, GLP-1RAs, SGLT-2Is) for patients with type 2 diabetes … development of hypoglycemic agents in recent years and the growth in the number of people with type 2 diabetes … Last updated on October 31, 2022 Objectives: This systematic review will assess the prevention and treatment … clinical practice guideline that will address diagnosis and staging of acute diverticulitis, nonsurgical treatment … Identifying candidates for therapy is complicated by risk stratification methods that demonstrate low
  10. srdrplus.ahrq.gov/published_projects?page=11
    October 25, 2022 - versus placebo or no treatment, recently approved medical therapies versus older therapies, and selective … One trial (n=461) found no differences between medical therapy versus placebo or no treatment in visual … versus placebo or no treatment, recently approved medical therapies versus older therapies, and selective … One trial (n=461) found no differences between medical therapy versus placebo or no treatment in visual … Statin therapy was not associated with increased risk of diabetes (RR 1.04, 95% CI, 0.92 to 1.19), though

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: